Management Issues in Conjunctival Tumours: Conjunctival Melanoma and Primary Acquired Melanosis.
Cohen VML, O'Day RF.
Ophthalmol Ther. 2019 Dec;8(4):501-510. doi: 10.1007/s40123-019-00219-8. Epub 2019 Nov 6.
Use of interferon alpha 2b to manage conjunctival primary acquired melanosis and conjunctival melanoma.
Cid-Bertomeu P, Huerva V.
Surv Ophthalmol. 2022 Sep-Oct;67(5):1391-1404. doi: 10.1016/j.survophthal.2022.03.003. Epub 2022 Mar 9.
Primary acquired melanosis/melanoma: utility of conjunctival map biopsy.
Soto H, Bowen RC, Raval V, Yeaney G, Singh A.
Br J Ophthalmol. 2022 May;106(5):605-609. doi: 10.1136/bjophthalmol-2020-317772. Epub 2020 Dec 18.
Management of Primary Acquired Melanosis, Nevus, and Conjunctival Melanoma.
Kao A, Afshar A, Bloomer M, Damato B.
Cancer Control. 2016 Apr;23(2):117-25. doi: 10.1177/107327481602300205.
Recurrence of Primary Acquired Melanosis and Conjunctival Intraepithelial Neoplasia.
Svedberg K.
Ocul Oncol Pathol. 2023 Feb;8(4-6):236-241. doi: 10.1159/000526985. Epub 2022 Sep 14.
Tumors of the conjunctiva and cornea.
Shields CL, Shields JA.
Indian J Ophthalmol. 2019 Dec;67(12):1930-1948. doi: 10.4103/ijo.IJO_2040_19.
Conjunctival Primary Acquired Melanosis: Is It Time for a New Terminology?
Jakobiec FA.
Am J Ophthalmol. 2016 Feb;162:3-19.e1. doi: 10.1016/j.ajo.2015.11.003. Epub 2015 Nov 10.
PRAME immunohistochemistry is useful in the evaluation of conjunctival melanomas, nevi, and primary acquired melanosis.
LeBlanc RE, Miller DM, Zegans ME.
J Cutan Pathol. 2021 Dec;48(12):1442-1448. doi: 10.1111/cup.14078. Epub 2021 Jun 18.
Conjunctival Primary Acquired Melanosis: Is it Time for a New Terminology?
Coupland SE, Damato BE.
Am J Ophthalmol. 2016 May;165:203-4. doi: 10.1016/j.ajo.2016.03.005. Epub 2016 Apr 1.
Spontaneous Regression of Unilateral Conjunctival Primary Acquired Melanosis.
Lando L, Krema H.
Ophthalmology. 2021 Sep;128(9):1324. doi: 10.1016/j.ophtha.2021.03.001.
